MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
On Oct. 29, 2025, the Alice L. Walton School of Medicine (AWSOM) celebrated its grand opening on the…
On Oct. 29, 2025, the U.S. Food and Drug Administration (FDA) announced it is aiming to reduce the…
On Oct. 20, 2025, Anthropic announced a new service called Claude of Life Sciences that uses artificial intelligence…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
On Oct. 10, 2025, Ypsomed announced it will establish its first manufacturing facility in the United States. The…
On Sept. 25, 2025, the operator of Pacific Northwest National Laboratory laid off 68 employees effective November 18, saying “unforeseen business circumstances” meant it wasn’t able to provide…
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
On Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency after reporting…
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
On Aug. 7, 2025, research scientists at Scripps Research announced a new platform that enables fast, scalable protein…
On Jul. 30, 2025, a study led by Northwestern Medicine shows that most U.S. adults have a “heart…
On Jul. 28, 2025, Kaiser Permanente Washington Health Research Institute (KPWHRI) and Kaiser Permanente Center for Health Research…
On Jul. 25, 2025, Simtra BioPharma announced the purchase from Cook Group of a 65-acre property (301 N….
On Jul. 17, 2025, More than 35 leading experts highlight the risks posed by rapidly advancing capabilities at…
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…